These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

483 related articles for article (PubMed ID: 37275904)

  • 1. Machine learning-based solution reveals cuproptosis features in inflammatory bowel disease.
    Liu L; Liang L; Yang C; Chen Y
    Front Immunol; 2023; 14():1136991. PubMed ID: 37275904
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Identification of cuproptosis-related subtypes, construction of a prognosis model, and tumor microenvironment landscape in gastric cancer.
    Wang J; Qin D; Tao Z; Wang B; Xie Y; Wang Y; Li B; Cao J; Qiao X; Zhong S; Hu X
    Front Immunol; 2022; 13():1056932. PubMed ID: 36479114
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Identification of hub cuproptosis related genes and immune cell infiltration characteristics in periodontitis.
    Liu S; Ge J; Chu Y; Cai S; Wu J; Gong A; Zhang J
    Front Immunol; 2023; 14():1164667. PubMed ID: 37215133
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A broad cuproptosis landscape in inflammatory bowel disease.
    Chen Y; Li X; Sun R; Ji J; Yang F; Tian W; Ji W; Huang Q
    Front Immunol; 2022; 13():1031539. PubMed ID: 36405733
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Development and validation of cuproptosis-related genes in synovitis during osteoarthritis progress.
    Chang B; Hu Z; Chen L; Jin Z; Yang Y
    Front Immunol; 2023; 14():1090596. PubMed ID: 36817415
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Identification of immune infiltration and cuproptosis-related molecular clusters in tuberculosis.
    Li S; Long Q; Nong L; Zheng Y; Meng X; Zhu Q
    Front Immunol; 2023; 14():1205741. PubMed ID: 37497230
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Identification and immuno-infiltration analysis of cuproptosis regulators in human spermatogenic dysfunction.
    Zhao M; Yu WX; Liu SJ; Deng YJ; Zhao ZW; Guo J; Gao QH
    Front Genet; 2023; 14():1115669. PubMed ID: 37065492
    [No Abstract]   [Full Text] [Related]  

  • 8. Comprehensive analysis of a cuproptosis-related ceRNA network implicates a potential endocrine therapy resistance mechanism in ER-positive breast cancer.
    Zhang D; Lu W; Zhuo Z; Wang Y; Zhang W; Zhang M
    BMC Med Genomics; 2023 May; 16(1):96. PubMed ID: 37143115
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Identification of immune infiltration and cuproptosis-related subgroups in Crohn's disease.
    Yuan Y; Fu M; Li N; Ye M
    Front Immunol; 2022; 13():1074271. PubMed ID: 36466876
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Identification and immunological characterization of cuproptosis-related molecular clusters in idiopathic pulmonary fibrosis disease.
    Shi X; Pan Z; Cai W; Zhang Y; Duo J; Liu R; Cai T
    Front Immunol; 2023; 14():1171445. PubMed ID: 37266442
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Characterization of cuproptosis identified immune microenvironment and prognosis in acute myeloid leukemia.
    Luo D; Liu S; Luo J; Chen H; He Z; Gao Z; Wen Z; Liu X; Xu N
    Clin Transl Oncol; 2023 Aug; 25(8):2393-2407. PubMed ID: 36826709
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Identification of cuproptosis-related biomarkers in dilated cardiomyopathy and potential therapeutic prediction of herbal medicines.
    Bian R; Wang Y; Li Z; Xu X
    Front Mol Biosci; 2023; 10():1154920. PubMed ID: 37168258
    [No Abstract]   [Full Text] [Related]  

  • 13. A novel cuproptosis-related gene signature of prognosis and immune microenvironment in head and neck squamous cell carcinoma cancer.
    Jiang X; Ke J; Jia L; An X; Ma H; Li Z; Yuan W
    J Cancer Res Clin Oncol; 2023 Jan; 149(1):203-218. PubMed ID: 36376617
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Identification and validation of potential diagnostic signature and immune cell infiltration for NAFLD based on cuproptosis-related genes by bioinformatics analysis and machine learning.
    Ouyang G; Wu Z; Liu Z; Pan G; Wang Y; Liu J; Guo J; Liu T; Huang G; Zeng Y; Wei Z; He S; Yuan G
    Front Immunol; 2023; 14():1251750. PubMed ID: 37822923
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evaluation the role of cuproptosis-related genes in the pathogenesis, diagnosis and molecular subtypes identification of atherosclerosis.
    Wang M; Cheng L; Xiang Q; Gao Z; Ding Y; Xie H; Chen X; Yu P; Shen L
    Heliyon; 2023 Oct; 9(10):e21158. PubMed ID: 37928399
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cuproptosis-related risk score predicts prognosis and characterizes the tumor microenvironment in colon adenocarcinoma.
    Wang J; Tao Z; Wang B; Xie Y; Wang Y; Li B; Cao J; Qiao X; Qin D; Zhong S; Hu X
    Front Oncol; 2023; 13():1152681. PubMed ID: 37333810
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Single-cell and bulk RNA-seq unveils the immune infiltration landscape associated with cuproptosis in cerebral cavernous malformations.
    Chen C; Bao Y; Ju S; Jiang C; Zou X; Zhang X; Chen L
    Biomark Res; 2024 Jun; 12(1):57. PubMed ID: 38835051
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Identification of Three Cuproptosis-specific Expressed Genes as Diagnostic Biomarkers and Therapeutic Targets for Atherosclerosis.
    Chen YT; Xu XH; Lin L; Tian S; Wu GF
    Int J Med Sci; 2023; 20(7):836-848. PubMed ID: 37324184
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A novel cuproptosis-related prognostic gene signature in adrenocortical carcinoma.
    Gao W; He X; Huangfu Q; Xie Y; Chen K; Sun C; Wei J; Wang B
    J Clin Lab Anal; 2023 Nov; 37(21-22):e24981. PubMed ID: 37997497
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prediction of risk and clinical outcome of cuproptosis in lung squamous carcinoma.
    Zhang Y; Zhou J; Li H; Liu Y; Li J
    BMC Pulm Med; 2023 Jun; 23(1):205. PubMed ID: 37308925
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 25.